Unexpected high incidence of tumours in thymectomized mice treated with anti-lymphocytic globulin and Mycobacterium leprae.
D008949:Adenoma, Pleomorphic; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001859:Bone Neoplasms; D005260:Female; D005354:Fibrosarcoma; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007890:Leiomyosarcoma; D007918:Leprosy; D008214:Lymphocytes / Q000276:immunology*; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D051379:Mice; D009166:Mycobacterium leprae / Q000472:pathogenicity*; D009374:Neoplasms, Experimental / Q000209:etiology / Q000473:pathology; D009500:Neutralization Tests; D012516:Osteosarcoma; D012509:Sarcoma; D013934:Thymectomy; D014594:Uterine Neoplasms
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents